Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) Posts Basic Consolidated EPS Of $-0.6746

0

Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT)managed to report annual basic consolidated EPS of $-0.6746, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-0.6746 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.0157.

EPS contribution from parent

Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) received of $-0.6746 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) contributed EPS of $-0.6746 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-0.6746.

What About Basic net EPS

The basic net EPS that Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) reported for the year ended 2015-12-31 stood at $-0.67. For the quarter ended 2015-12-31, the company posted basic net EPS of $-0.67.

What About Consolidated Diluted EPS?

Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-0.6746. For the quarter ended 2015-12-31 the metric was$-0.6746.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-0.6746 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-0.6746.

Net diluted EPS

Net diluted EPS posted by Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) for the year ended 2015-12-31 was $-0.67. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-0.67.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) said that it parent company boosted its diluted EPS by$-0.6746 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-0.6746.

The company reported net basic EPS of $-0.67 for the year ended 2015-12-31 and net basic EPS of $-0.67 for the quarter ended 2015-12-31.

The number of Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 32.439. That compares with 32.439 basic shares outstanding for the quarter ended 2015-12-31.

Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) had 32.439 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 32.439.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 13 times, 1 visits today)